High penetration drugs and their compositions thereof for treatment of parkinson diseases

  • US 9,718,766 B2
  • Filed: 09/15/2015
  • Issued: 08/01/2017
  • Est. Priority Date: 03/15/2013
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating Parkinson disease in a subject comprising administering transdermally a pharmaceutical composition comprising one or more high penetration pro-drugs selected from Structure Pro-L-Dopa-1, Structure Pro-L-Dopa-2, Structure Pro-L-Dopa-3, Structure Pro-L-Dopa-4, Structure Pro-L-Dopa-5, Structure Pro-dopamine-1, Structure Pro-dopamine-2, Structure Pro-dopamine-3, Structure Pro-dopamine-4, and Structure Pro-dopamine-5:

View all claims

    Thank you for your feedback